SNORA71 and neoplasm: A Pan-cancer study using TCGA small RNA-seq data from 31 cancer types (excluding glioblastoma) identified 46 clinically relevant snoRNAs (63), including snoRA71, which showed alterations in at least 12 different tumor types.